Subsequently, 55 patients with HCC were divided into a relatively high lnc-ZEB2-19 expression group (n=28, expression levels≥ median) and a relatively low lnc-ZEB2-19 expression group (n=27, expression levels < median) to assess the correlation between lnc-ZEB2-19 expression and malignant tumor characteristics. Here, ZEB2 is linked to hepatocellular carcinoma.